Cardiac contractility modulation in non-responders to cardiac resynchronization therapy

Europace

Volumn 10, Issue 12, 2008, Pages 1375-1380

  Nagele H ^a   Behrens, S ^a   Eisermann, C ^a  

^a Medical Department   (Germany)

Author keywords

Cardiac resynchronization therapy; Heart failure; Non excitatory stimulation; Non responder

Indexed keywords

AMIODARONE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVERSION; CATHETER; CLINICAL ARTICLE; DEFIBRILLATOR; DEVICE; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE DP-DT; HEART MUSCLE CONTRACTILITY; HEMODYNAMIC PARAMETERS; HEMOFILTRATION; HUMAN; IMPLANTATION; KIDNEY FAILURE; MALE; MITRAL VALVE REGURGITATION; MORTALITY; PNEUMONIA; PNEUMOTHORAX; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRE; TREATMENT OUTCOME; TRICUSPID VALVE REGURGITATION;

AGED; CARDIAC PACING, ARTIFICIAL; FEMALE; HEART FAILURE; HUMANS; MALE; TREATMENT FAILURE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 56749169397     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eun257     Document Type: Article

References (22)

1. Cleland JGF, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L et al., For the Cardiac Resynchronization - Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-49. Epub 2005 Mar 7.
2. Díaz-Infante E, Mont L, Leal J, García-Bolao I, Fernández-Lozano I, Hernández-Madrid A et al. Predictors of lack of response to resynchronization therapy. Am J Cardiol 2005;95:1436-40.
3. Pappone C, Augello G, Rosanio S, Vicedomini G, Santinelli V, Romano M et al. First human chronic experience with cardiac contractility modulation by nonexcitatory electrical currents for treating systolic heart failure: mid-term safety and efficacy results from a multicenter study. J Cardiovasc Electrophysiol 2004;15:418-27.
4. Stix G, Borggrefe M, Wolpert C, Hindricks G, Kottkamp H, Bocker D et al. Chronic electrical stimulation during the absolute refractory period of the myocardium improves severe heart failure. Eur Heart J 2004;25:650-5.
5. Neelagaru SB, Sanchez JE, Lau SK, Greenberg SM, Raval NY, Worley S et al. Nonexcitatory, cardiac contractility modulation electrical impulses: feasibility study for advanced heart failure in patients with normal QRS duration. Heart-Rhythm 2006;3:1140-7.
6. Sabbah HN, Gupta RC, Rastogi S, Mishra S, Mika Y, Burkhoff D. Treating heart failure with cardiac contractility modulation electrical signals. Curr Heart Fail Rep 2006;3:21-4.
7. Wood EH, Heppner RL, Weidmann S.Inotropic effects of electric currents: 2. Hypotheses: calcium movements, excitation-contraction coupling and inotropic effects. Circ Res 1969;24:409-45.
8. Butter C, Rastogi S, Minden HH, Meyhöfer J, Burkhoff D, Sabbah HN. Cardiac contractility modulation electrical signals improve myocardial gene expression in patients with heart failure. J Am Coll Cardiol 2008;51:1784-9.
9. Imai M, Rastogi S, Gupta RC, Mishra S, Sharov VG, Stanley WC et al. Therapy with cardiac contractility modulation electrical signals improves left ventricular function and remodelling in dogs with chronic heart failure. J Am Coll Cardiol 2007;49:2120-8.
10. Butter C, Wellnhofer E, Schlegl M, Winbeck G, Fleck E, Sabbah HN. Enhanced inotropic state of the failing left ventricle by cardiac contractility modulation electrical signals is not associated with increased myocardial oxygen consumption. J Card Fail 2007;13:137-42.
11. Borggrefe MM, Lawo T, Butter C, Schmidinger H, Lunati M, Pieske B et al. Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure. Eur Heart J 2008;29:1019-28.
12. Butter C, Meyhofer J, Seifert M, Neuss M, Minden HH. First use of cardiac contractility modulation (CCM) in a patient failing CRT therapy: clinical and technical aspects of combined therapies. Eur J Heart Fail 2007;9:955-8.
13. Rector TS, Kubo SH, Cohn JN. Patients' self-assessment of their congestive heart failure. Part 2: content, reliability and validity of a new measure, the Minnesota Living with Heart Failure questionnaire. Heart Failure 1987;198-209.
14. Goodlin SJ. Palliative care for end-stage heart failure. Curr Heart Fail Rep 2005;2:155-60.
15. Mebazaa A, Nieminen MS, Packer M, Cohen-Solal A, Kleber FX, Pocock SJ et al., SURVIVE Investigators. Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial. JAMA 2007;297:1883-91.
16. Rose EA, Gelijns AC, Moskowitz AJ et al. Long-term mechanical left ventricular assistance for end stage heart failure. N Engl J Med 2001;345:1435-43.
17. Segers VF, Lee RT. Stem-cell therapy for cardiac disease. Nature 2008;451:937-42.
18. Ailawadi G, Kron IL. New strategies for surgical management of ischemic cardiomyopathy. Expert Rev Cardiovasc Ther 2008;6:521-30.
19. Cadeiras M, von Bayern MP, Deng MC. Cardiac transplantation: any role left? Heart Fail Clin 2007;3:321-47.
20. Pappone C, Rosanio S, Burkhoff D et al. Cardiac contractility modulation by electric currents applied during the refractory period in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 2002;90:1307-13.
21. Burkhoff D, Ben Haim SA. Nonexcitatory electrical signals for enhancing ventricular contractility: rationale and initial investigations of an experimental treatment for heart failure. Am J Physiol Heart Circ Physiol 2005;288:H2550-H2556.
22. Blank M, Goodman R. Initial interactions in electromagnetic field induced biosynthesis. J Cell Physiol 2004;199:359-63.